Sex-differences in the impact of metabolic syndrome on tissue plasminogen activator-induced recanalization.
Tsivgoulis
Georgios
G
Voumvourakis
Konstantinos
K
Stamboulis
Elefterios
E
D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications*; D012727:Sex Characteristics; D020521:Stroke / Q000150:complications* / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator